Cadila Pharma working on super-bug NDM-1; soon to commercialize India’s first VLP vaccine

Rajiv Modi, Chairman and managing director of Cadila Pharmaceuticals Ltd said "The VLP technology flu vaccine would be commericialised within next 12 to 18 months" AHMEDABAD: Ahmedabad-based Cadila Pharmaceuticals Ltd, a privately owned drug company by Modi family, will commercialise India’s first virus like particle (VLP) based technology seasonal flu vaccine within next 18 months. The company is also working on antibiotic resistance breaker (ARBs) technology to solve the problem rising from the super-bug – New Delhi Metallo-beta-lactamase-1 (NDM-1).

Rajiv Modi, Chairman and managing director of Cadila Pharmaceuticals Ltd said “The VLP technology ..

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s